Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Vistagen Therapeutics' Depreciation & Amortization (CF) came in at $50,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 5.7% from $53,000 a year earlier and down 3.8% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Vistagen Therapeutics reported Depreciation & Amortization (CF) of $208,000, up 20.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $199,000, up 32.7% from FY2025.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 11.1% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $150,000 in FY2025 (+18.1%), $127,000 in FY2024 (-2.3%), $130,000 in FY2023 (-15.3%) and $153,500 in FY2022 (+30.5%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Depreciation & Amortization (CF) since fiscal Q1 2026.
  • Year-over-year, Depreciation & Amortization (CF) increased in seven of the last eight quarters, with growth averaging 25.1%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q3 2022 (growth of 65.5%), and the weakest in fiscal Q3 2023 (a decline of 30.0%).
  • Business Quant data shows VTGN's Depreciation & Amortization (CF) at $52,000 (Q1 2027), $52,000 (Q4 2026) and $54,000 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 33,835.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 545.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.12 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 192.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 726.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 132.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 50,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 50,000.00
Jun 30, 2026 52,000.00
Mar 31, 2026 52,000.00
Dec 31, 2025 54,000.00
Sep 30, 2025 53,000.00
Jun 30, 2025 40,000.00
Mar 31, 2025 40,000.00
Dec 31, 2024 39,000.00
Sep 30, 2024 37,000.00
Jun 30, 2024 34,000.00
Mar 31, 2024 33,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 31,000.00
Jun 30, 2023 32,000.00
Mar 31, 2023 33,800.00
Dec 31, 2022 30,600.00
Sep 30, 2022 33,300.00
Jun 30, 2022 32,300.00
Mar 31, 2022 38,600.00
Dec 31, 2021 43,700.00
API Access

Vistagen Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VTGN&period=max&api_key=YOUR_API_KEY